Holly E Johnston, OTR,CHT | |
2750 Broadway St, Boulder, CO 80304-3573 | |
(303) 440-3034 | |
(303) 402-1665 |
Full Name | Holly E Johnston |
---|---|
Gender | Female |
Speciality | Occupational Therapy |
Experience | 36 Years |
Location | 2750 Broadway St, Boulder, Colorado |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659536902 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XH1200X | Occupational Therapist - Hand | OT0001330 (Colorado) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Uchealth Community Services | 5395024905 | 98 |
Certified Hand Therapy Services Llc | 8426394107 | 5 |
News Archive
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the "black market" for medicines and supplies, new research shows.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 1 days ago
Provider Name | Scl Health Medical Group - Denver Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1083021083 PECOS PAC ID: 0840513552 Enrollment ID: O20150106000131 |
News Archive
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the "black market" for medicines and supplies, new research shows.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 1 days ago
Provider Name | Uchealth Community Services |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1841740693 PECOS PAC ID: 5395024905 Enrollment ID: O20161122000429 |
News Archive
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the "black market" for medicines and supplies, new research shows.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 1 days ago
Provider Name | Orthopedic Centers Of Colorado |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1801339502 PECOS PAC ID: 2365714540 Enrollment ID: O20170823001317 |
News Archive
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the "black market" for medicines and supplies, new research shows.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 1 days ago
Provider Name | Certified Hand Therapy Services Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1124599956 PECOS PAC ID: 8426394107 Enrollment ID: O20190117001047 |
News Archive
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the "black market" for medicines and supplies, new research shows.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Holly E Johnston, OTR,CHT Po Box 5718, Kalispell, MT 59903-5718 Ph: (406) 756-0134 | Holly E Johnston, OTR,CHT 2750 Broadway St, Boulder, CO 80304-3573 Ph: (303) 440-3034 |
News Archive
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
Altruism and a lack of access and affordability are three reasons why people with chronic illnesses are turning to the "black market" for medicines and supplies, new research shows.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 1 days ago
Kathleen Anne Stumpf, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 303-447-1010 | |
Dhori Meyer Knud-hansen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2100 | |
Amalia Beard, MOT, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5412 Idylwild Trl, Boulder, CO 80301 Phone: 303-579-6149 | |
Celia Galvin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6214 Willow Ln, Boulder, CO 80301 Phone: 314-882-4569 | |
Courtney Whalen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4740 Pearl Pkwy, Boulder, CO 80301 Phone: 303-449-2730 | |
Jakki Ruzich, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3850 Paseo Del Prado St Apt 36, Boulder, CO 80301 Phone: 702-612-7533 | |
David Mangine, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7869 Brockway Dr, Boulder, CO 80303 Phone: 303-888-2819 |